Statins are linked with reduced mortality in patients with peripheral arterial disease, even when started late after diagnosis, reports a study presented today at ESC Congress 2019 together with the World Congress of Cardiology. ...
Sep 3, 2019
0
4
Concerted effort by friends, family and non-physician health workers can make a dramatic difference in reducing the risk factors for heart problems in patients with hypertension, an international study by Hamilton researchers ...
Sep 2, 2019
1
15
Genetic high cholesterol is underdiagnosed and undertreated, according to research presented today at ESC Congress 2019 together with the World Congress of Cardiology. Screening could identify patients and family members ...
Sep 1, 2019
0
3
A low-cost text-messaging programme improves blood sugar control in patients with diabetes and coronary heart disease. That's the finding of the CHAT-DM randomised trial reported today at ESC Congress 2019 together with the ...
Aug 31, 2019
0
6
Low-density lipoprotein (LDL) cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients. That's one of the main messages of the European Society ...
Aug 31, 2019
0
5
A new study from the University of Bristol has linked bone strength to the timing of puberty.
Aug 9, 2019
0
120
(HealthDay)—As part of a literature review, published in the June issue of the Annals of Oncology, recommendations are presented for the management of bone health in survivors of childhood cancer.
Aug 6, 2019
0
2
(HealthDay)—High variability in body mass index (BMI) and high-density lipoprotein cholesterol (HDL-C) during childhood are associated with an increased risk for later-life diabetes, according to a study published online ...
Aug 1, 2019
0
5
Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of heart disease later in life, regardless of later in life exposure to these risk factors, according to research published today ...
Jul 15, 2019
0
2
Researchers have shown that among users of pre-exposure prophylaxis (PrEP) to prevent against AIDS that includes tenofovir (Truvada), those with daily use—very high adherence—had only about a 1% average decrease in bone ...
Jul 15, 2019
0
2
